Approval · Notice of Compliance 6030 · 1997
MUMPSVAX: Notice of Compliance 6030
Issued August 20, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6030
- Date
- August 20, 1997
- Company
- Merck Frosst Canada Inc.Kirkland, QC, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to manufacturing site
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MUMPSVAX | Not yet assigned | — |
Medicinal ingredients
- MUMPS VACCINE LIVE ATTENUATED 5,000 UNIT per 0.5ML